![]() |
市場調查報告書
商品編碼
1439304
醫用氧氣濃縮器 - 全球市場考量、競爭格局、市場預測 (2030)Medical Oxygen Concentrators - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
在預測期(2024-2030年),全球醫用氧氣機市場規模預計將以 5.63% 的複合年增長率成長。 醫用製氧機需求量的增加主要是由於慢性阻塞性肺病(COPD)、睡眠呼吸中止症、低氧血症、肺水腫等呼吸系統疾病盛行率不斷上升,以及老年患者、臥床患者的進一步增加所致患者的需求增加,全球COVID-19大流行後對醫用製氧機的需求激增,這些因素預計將增強市場,並有助於醫用製氧機市場的成長。
醫用製氧機市場動態
產品需求的主要促進因素是慢性阻塞性肺病(COPD)、睡眠呼吸中止症、低氧血症和肺水腫等呼吸系統疾病的盛行率不斷上升,以及老年人和臥床患者的盛行率不斷上升。
根據世界衛生組織 (WHO) (2022) 的數據,慢性阻塞性肺病 (COPD) 是世界第三大死因。 慢性阻塞性肺病需要氧氣治療來控制氧氣水平的下降,而慢性阻塞性肺病盛行率的增加增加了對制氧機的需求。 根據阻塞性肺病負擔 (BOLD) 報告,2020 年,每年有近 300 萬人死於慢性阻塞性肺病。 根據相同的數據,預計未來 40 年慢性阻塞性肺病將會增加,到 2060 年,每年可能有超過 540 萬人死於慢性阻塞性肺病。 慢性阻塞性肺病隨著吸菸率的增加而增加。 根據美國疾病管制與預防中心的數據,2020 年,每 100 名 18 歲及以上的美國成年人中就有近 13 人(12.5%)吸菸。 據估計,目前美國有 3,080 萬成年人吸煙,超過 1,600 萬美國人患有與吸煙相關的疾病。 吸菸率的增加將推高慢性阻塞性肺病的盛行率,對制氧機市場產生正面影響。
此外,根據國際呼吸學會論壇發布的《呼吸系統疾病全球影響報告》(2022年第3版)顯示,2019年有超過1億人患有睡眠呼吸障礙。 對於睡眠呼吸中止症等睡眠障礙,採用氧氣治療來控制氧氣水平,預計這將進一步增加對醫用氧氣機的需求。 預計 2024 年至 2030 年期間,生活方式的壓力也將導致年輕人睡眠障礙的增加。
室內空氣污染物的增加和吸菸者數量的增加也推動了醫用製氧機市場的成長。 增加接觸空氣污染會導致呼吸道疾病。 據美國肺臟協會稱,到 2022 年,超過十分之四的美國人將生活在空氣品質較差的地區。 文件稱,超過 1.35 億人居住在 2022 年臭氧或粒狀物污染空氣狀況評級為 F 的縣。
大量的老年人和臥床病患也是使用醫用氧氣機的原因之一。 根據全球慢性阻塞性肺病倡議(2020)的報告,慢性阻塞性肺病的盛行率隨著年齡的增長而迅速增加,其中60歲以上人口的盛行率最高。 隨著年齡的增長,呼吸系統會變得越來越弱,體內的氧氣含量也會降低。
呼吸困難,也稱為呼吸短促,在老年人中很常見,影響大約 30% 的 65 歲以上人群。 呼吸困難被認為是一種主要症狀,醫用製氧機用於治療這種情況,從而促進了醫療設備市場的成長。
本報告研究和分析了全球醫用氧氣機市場,提供市場規模和預測、促進因素和挑戰、公司和產品概況等。
Medical Oxygen Concentrators Market By Product (Stationary, Portable), By Technology (Continuous Flow, Pulse Flow, Both), By End-User (Homecare, Hospitals And Clinics, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increased prevelence of respiratory disorders like chornic obstructive pulmonary disease (COPD) and increased need for medical oxygen concentrators for geriatrics and bedridden patients
The global medical oxygen concentrators market is estimated to advance at a CAGR of 5.63% during the forecast period (2024-2030). The increase in demand for Medical Oxygen Concentrators is primarily attributed to the increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness, further increased demand in geriatric and bedridden patients, and steep rise in demand of medical oxygen concentrators after COVID-19 pandemic across the world are anticipated to bolster the market, thereby contributing to the growth of the Medical Oxygen Concentrators market during the forecast period from 2024-2030.
Medical Oxygen Concentrators Market Dynamics:
The major factors responsible for product demand is increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness and increased prevalence of geriatric and bedridden patients.
According to World Health Organization (WHO) 2022, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. Oxygen therapy is needed for COPD to control the oxygen level drops, increasing prevalence of COPD will increase the demand for oxygen concentrators. According to Burden of Obstructive Lung Disease (BOLD) report, 2020, there are nearly three million deaths annually due to COPD. Also as per the same source, COPD is expected to rise over the next 40 years and by 2060 there may be more than 5.4 million deaths annually due to COPD. COPD is increased with increased prevalence of smoking. As per Centers for Disease Control and Prevention, in 2020, nearly 13 of every 100 U.S. adults aged 18 years or older (12.5%) smoked cigarettes. An estimated 30.8 million adults in the United States currently smoke cigarettes and more than 16 million Americans live with a smoking-related disease. This increasing prevalence of smoking shoot up the prevalence of COPD, effecting the market of oxygen concentrators positively.
Moreover, according to the Global Impact of Respiratory Disease report (third edition, published in 2022) published by Forum of International Respiratory Societies, in 2019 more than 100 million people suffer from sleep-disordered breathing. During sleep-disorders like sleep-apnea oxygen therapy is provided to control the oxygen level, which is further expected to increase the demand for medical oxygen concentrators. Stressful lifestyle will also contribute to increase the sleep disorders in young age population during the forecasting period from 2024-2030.
Increase in indoor air pollutants as well as increase in pollution of active smokers, is also responsible for propelling the growth of the medical oxygen concentrator market. The increased exposure to air pollution can cause respiratory ailments in people. According the American Lung Association, 2022 more than four in ten Americans live where the air quality is not good. As per the same source, more than 135 million people live in counties that received an F for either ozone or particle pollution in "State of the Air" 2022.
Also, the prevalence of geriatric and bedridden patients is another factor responsible for the use of these Medical Oxygen Concentrators. According to the Global Initiative for Chronic Obstructive Lung Disease 2020 report, the prevalence of COPD increased steeply with age, with the highest prevalence among those with more than 60 years age. The respiratory system becomes weak with age, lowering the oxygen level in the body.
Dyspnea also known as shortness of breath is highly prevalent in the elderly, and is reported by approximately 30% of individuals greater than 65 years of age. In dyspnea difficulty in breathing is observed as a major symptom, medical oxygen concentrators can be provided to cure this symptom; increasing the market growth of the medical device.
Moreover, according to WHO 2022 report, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22% and by 2030, 1 in 6 people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
Furthermore, there was more need for oxygen concentrators during COVID-19 infection. During second wave of COVID-19 people purchased oxygen concentrators fearing the shortage of medical oxygen. Moreover, people with COVID-19 were at increased risk for pneumonia and hypoxemia, which are major predictor of mortality. People with these complications were recommended proper oxygen supply. This supply can be given by medical oxygen concentrators. This increased the demand of medical oxygen concentrators in the market. The rise in demand had led to hike in prices.
But, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemic made the resumption of regular healthcare services, which will keep a steady demand for these products on course in the Medical Oxygen Concentrators market.
Therefore, with proper monitoring and care the mortality and hospitalization due to respiratory ailment can be prevented. Hence, the growth of the Medical Oxygen Concentrators Market is expected to rise during the forecast period from 2024 to 2030.
However, the stringent regulatory process and high cost of devices may be certain limiting factors of the Medical Oxygen Concentrators market growth.
Medical Oxygen Concentrators Market Segment Analysis:
Medical oxygen concentrators market by product (stationary, portable), by technology (continuous flow, pulse flow, both), by end-user (homecare, hospitals and clinics, others) and by geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Technology segment of the Medical Oxygen Concentrators market, the Pulse Flow segment is estimated to hold a significant market share in the year 2023. This can be ascribed to the various advantages that are associated with the pulse flow oxygen concentrators.
Pulse flow oxygen concentrators puffs oxygen into the nasal passageway, through a cannula, with each breath. In these concentrators oxygen is delivered only during inhalation and is stored during exhalation thereby saving the amount of oxygen as well as life of battery used to operate the concentrators. This is useful when the patient is doing some other activity like drinking water. These device are mostly used by the patient in daytime as compared to nighttime because the breathing rate is not steady while sleeping.
Furthermore, advantageous properties such as more energy efficiency due to rest period between two breaths, increase in battery life due to rest period and smaller size. As well, doctors' advice pulse flow oxygen concentrators in moderate to severe respiratory ailments, where these devices are effectively used.
Moreover, various new products are coming into the market which in turn depicts the high demand of these products. For instance, In March 2022, Belluscura announced that the X-PLO2R pulse flow portable oxygen concentrator manufactured by Belluscura has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). X-PLO2R is a compact, quiet, weighing only 3.25 pounds, compact and portable oxygen concentrators.
Therefore, the advantages offered by the Pulse Flow in Medical Oxygen Concentrators are predicted to contribute to the increasing demand, thereby driving the growth of the overall Medical Oxygen Concentrators market during the forecast period.
North America is expected to dominate the overall Medical Oxygen Concentrators Market:
Among all the regions, North America is expected to account for the largest share in the global Medical Oxygen Concentrators market in the year 2023. Factors such as the growing prevalence of various respiratory ailments like COPD, hypoxia and others, increasing prevalence of geriatric and bedridden patients, increase in air pollution and smoking are some of the key factors which are expected to aid in the growth of North America Medical Oxygen Concentrators Market.
For instance, according to the WHO 2022, (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. The mortality rate can be reduced by giving emergency aid to serious patients by the providing medical oxygen concentrators to the patient, increasing the demand of device in the market.
Furthermore, as per the Centers for Disease Control and Prevention (CDC) 2022, COPD makes breathing difficult for the 16 million Americans. The difficulty in breathing can be managed by providing the medical oxygen concentrators to the patients thereby driving the market in North America.
Additionally, according to the Pan American Health Organization (PAHO), in 2019, the chronic respiratory disease accounts for 534,242 deaths in both sexes, 267,516 (50%) deaths in men and 266,725 (50%) in women. The increase in prevalence of chronic respiratory disease and deaths caused by them can be controlled by providing the patients with medical devices like oxygen concentrators and educating them about the usage of the device, will affect the market of the medical device positively.
Moreover, according to CDC, in 2020, preterm birth affected 1 of every 10 infants born in the United States. In preterm birth, organs like lungs, heart, and brain may not be fully developed. If the lungs are not developed properly then external source is used to provide oxygen to the baby. Medical oxygen concentrators can be used to provide oxygen in the above case. The prevalence is expected to rise at a significant rate in the forecast period. Thus, the burgeoning cases of premature births will contribute to the growth of the Medical Oxygen Concentrators market.
Furthermore, the government of the North America is actively involved in relevant organizations which can provide proper COPD management guidance to the patients. National Center for Immunization and Respiratory Diseases is under a mission to prevent the disease, disability, and death through immunization and to control of respiratory and related diseases. As the awareness of treatment and management of COPD will increase in the patient, use of oxygen concentrators will also increases in the market, thereby fostering the market in North America.
Therefore, the rising prevalence of these respiratory disorders in the North America would result in the rising demand for treatments that make use of Medical Oxygen Concentrators, which in turn would provide a conducive growth environment for the Medical Oxygen Concentrators market in the North American region.
Hence, the interplay of various factors such as the presence of a large respiratory ailment patient population, increased prevalence of preterm births in the region as well as awareness created among the patients by government and organizations is expected to boost the North America Medical Oxygen Concentrators market during the forecast period.
Medical Oxygen Concentrators Market Key Players:
Some of the key market players operating in the Medical Oxygen Concentrators market include Koninklijke Philips N.V., Invacare corporation, DeVilbiss Healthcare LLC, Inogen,Inc., Nidek Medical, O2 Concepts, Teijin Limited, Supera Anesthesia Innovations, GCE Group, CAIRE, OxyGo, LLC, Precision medical, Inc., Graham Field, Belluscura , Besco Medical Limited, OSI - Oxygen Solutions Inc, NGK Spark Plug Co Ltd, Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Narang Medical Limited, Topson and others.
Recent Developmental Activities in the Medical Oxygen Concentrators Market:
In March 2022, Belluscura have signed a three-year manufacturing agreement for its X-PLO2r portable oxygen concentrator with InnoMax Medical Technology in China.
In March 2022, Belluscura announced that the X-PLO2R pulse-flow portable oxygen concentrator manufactured by Belluscura has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA).
In March 2022, OxyGo announced that they have acquired LIFE Corporation, a manufacturer of portable emergency oxygen and CPR administration equipment. The acquisition will allow OxyGo to further expand its expertise in the oxygen market.
Key Takeaways from the Medical Oxygen Concentrators Market Report Study
Target Audience who can be benefited from this Medical Oxygen Concentrators Market Report Study
Frequently Asked Questions for Medical Oxygen Concentrators Market:
Medical Oxygen Concentrators are medical devices that provides supplemental oxygen to the patients with breathing disorder. The device filter the surrounding air, compressing it to the required density and then deliver the purified medical grade oxygen. The device is equipped with special filters and sieve beds which helps to remove nitrogen from the air and deliver completely purified oxygen to the patient.
The global medical oxygen concentrators market is estimated to advance at a CAGR of 5.63% during the forecast period (2024-2030).
The Medical Oxygen Concentrators market is witnessing a positive market growth owing to the increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea and other respiratory illness, increased demand in geriatric and bedridden patients, and due to unexpected demand of medical oxygen concentrators during COVID-19 pandemic across the world are anticipated to bolster the market.
Some of the key market players operating in the Medical Oxygen Concentrators market include Koninklijke Philips N.V., Invacare corporation, DeVilbiss Healthcare LLC, Inogen,Inc., Nidek Medical India, O2 Concepts, Teijin Aramid B.V, Supera Anesthesia Innovations, GCE Group, CAIRE Inc., OxyGo, Precision medical, Inc., GF HEALTH PRODUCTS, INC., Belluscura, Besco, OSI - Oxygen Solutions Inc, NGK Spark Plug Co Ltd, Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Narang Medical Limited, Topson and others.
North America is expected to hold the highest share in the revenue in the Medical Oxygen Concentrators market during the forecast period. Factors such as the growing prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness and increased demand in geriatric and bedridden patients are expected to aid in the growth of the North America Medical Oxygen Concentrators Market in this region.